Document Details
Form
Filing Date
March 27, 2024
Document Date
March 27, 2024
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Rapport Therapeutics, Inc.
Issuer
RAPPORT THERAPEUTICS, INC.